Related Experiment Video
Updated: Mar 15, 2026

MISSION esiRNA for RNAi Screening in Mammalian Cells
Published on: May 12, 2010
In Vitro High-Throughput RNAi Screening to Accelerate the Process of Target Identification and Drug Development
Hongwei Yin1, Michelle Kassner2
1Cancer and Cell Biology Division (CCB), Translational Genomics Research Institute (TGen), 445 N. Fifth Street, Phoenix, AZ, 85004, USA. hyin@tgen.org.
Abstract:
High-throughput RNA interference (HT-RNAi) is a powerful tool that can be used to knock down gene expression in order to identify novel genes and pathways involved in many cellular processes. It is a systematic, yet unbiased, approach to identify essential or synthetic lethal genes that promote cell survival in diseased cells as well as genes that confer resistance or sensitivity to drug treatment. This information serves as a foundation for enhancing current treatments for cancer and other diseases by identifying new drug targets, uncovering potential combination therapies, and helping clinicians match patients with the most effective treatment based on genetic information. Here, we describe the method of performing an in vitro HT-RNAi screen using chemically synthesized siRNA.
More Related Videos
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Experimental RNAi

